Comparison of Modified Labor Induction Strategies for Pregnant Women at a Single Tertiary Center Before and During the COVID-19 Pandemic.

Comparison of Modified Labor Induction Strategies for Pregnant Women at a Single Tertiary Center Before and During the COVID-19 Pandemic.

Publication date: Dec 05, 2024

The COVID-19 pandemic has substantially impacted healthcare systems and obstetric practices worldwide. Labor induction is a common procedure for preventing obstetric complications in high-risk populations. This study evaluated perinatal outcomes of labor induction using a modified management protocol in a tertiary care center during the COVID-19 pandemic. We conducted a retrospective study by reviewing electronic structured delivery records of women who underwent elective labor induction between June 2020 and October 2022. We analyzed maternal characteristics, maternal outcomes, and neonatal outcomes during the pre-pandemic (June 2020 to May 2021) and pandemic periods (May 2021 to October 2022). The study included 976 cases: 325 pregnancies in the pre-pandemic group and 651 in the pandemic group. The pandemic group showed earlier gestational age at delivery (39 vs. 40 weeks, p < 0. 01) and lower body mass index (27. 1 vs. 27. 5 kg/m, p = 0. 03). During the pandemic period, we observed a significant increase in labor induction cases and a decrease in cesarean sections. Neonatal outcomes, including Apgar scores and intensive care admissions, showed no significant differences between groups. Subgroup analysis identified advanced maternal age (OR = 1. 08; 95% CI = 1. 03-1. 14; p < 0. 01) and primiparity (OR = 5. 24; 95% CI = 2. 75-9. 99; p < 0. 01) as independent risk factors for cesarean delivery. Even under modified protocols for labor induction during the COVID-19 pandemic, more pregnancies underwent labor induction while achieving a significant reduction in cesarean sections. Advanced maternal age and primiparity were identified as independent risk factors associated with cesarean delivery.

Open Access PDF

Concepts Keywords
Healthcare cesarean section
June COVID-19 pandemic
Pandemic fetal outcomes
Pregnant labor induction
maternal outcomes

Semantics

Type Source Name
disease MESH COVID-19 Pandemic
disease MESH complications
drug DRUGBANK Coenzyme M
disease MESH fetal growth restriction
disease MESH infection
disease IDO pathogen
disease MESH community transmission
disease MESH preterm birth
disease MESH preeclampsia
disease MESH stillbirth
disease MESH respiratory distress syndrome
disease MESH fetal demise
disease IDO blood
drug DRUGBANK Methionine
disease MESH emergencies
drug DRUGBANK Trestolone
drug DRUGBANK Dinoprostone
drug DRUGBANK Misoprostol
drug DRUGBANK Oxytocin
drug DRUGBANK Methylergometrine
disease MESH fetal distress
disease MESH morbidity
disease IDO process
disease MESH privacy
disease MESH multiple pregnancies
disease MESH fetal anomalies
disease MESH postpartum hemorrhage
disease MESH maternal death
disease MESH pregnancy induced hypertension
disease MESH gestational diabetes mellitus
disease MESH hypertension
disease MESH diabetes mellitus
disease MESH autoimmune diseases

Original Article

(Visited 1 times, 1 visits today)